DAPK1 and neoplasm: This indicates a close relationship of DAPK1 with the aggressiveness of PTC cancer (tumor size, lymph node metastasis, and treatment-refractory) and suggests DAPK1 as a therapeutic target and an independent prognostic marker in thyroid cancer.